Biocon Ltd.
General
Supreme Court's free testing order may hinder virus fight, warn business leaders
A decision by the Supreme Court of India to make testing for coronavirus free places an unfair financial burden on ......
Healthcare
True North to invest $75 mn in Biocon's biosimilar unit
Indian biotechnology firm Biocon Ltd on Monday said that private equity firm True North will invest Rs 536.25 crore ($74.84 ......
Healthcare
Biocon elevates finance chief Siddharth Mittal as CEO
Biocon Ltd said on Tuesday it has appointed Siddharth Mittal as chief executive officer and joint managing director, in another...
Healthcare
Biocon buys Pfizer's R&D facility to boost biosimilars development
Indian biotechnology firm Biocon Ltd on Tuesday said it has acquired a Chennai-based research and development (R&D) facility...
General
Grapevine: Temasek, TrueNorth, CPPIB eye Biocon unit stake; PayU may buy PaySense
Singapore state investor Temasek, private equity firm TrueNorth, and Canadian Pension Plan Investment Board (CPPIB) are in separate...
Healthcare
True North makes partial exit from drug research firm with strong gains
Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains ......
General
Budget needs to give a push to healthcare agenda
A healthy workforce is critical for Prime Minister Narendra Modi’s ‘Make in India’ mantra to rev up India’s economic growth. ......
Healthcare
IVFA-backed Syngene makes strong market debut, ends day 1 with 24% gain
Syngene International Ltd, the research and development subsidiary of Indian biopharmaceutical major Biocon Ltd, made a strong debut on the ......
Healthcare
Biocon to open IPO of R&D arm Syngene end of this month, fixes price band
Biopharmaceutical major Biocon Ltd has fixed the price band for the initial public offering (IPO) of its research and development ......
Healthcare
Biocon to sell 10% stake in IVFA-backed R&D arm Syngene through offer-for-sale
Biopharmaceutical major Biocon Ltd's research and development arm Syngene International Ltd has filed draft red herring prospectus (DRHP) with securities ......